Related Experiment Video
Updated: Jul 1, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Progressive multifocal leukoencephalopathy in a lung transplant recipient
Jason Sakizadeh1, Michael J Davis2, Lauren Fontana2
1University of Minnesota Medical School Twin Cities Campus Minneapolis MN USA.
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a rare and fatal demyelinating disease of the central nervous system (CNS). The case we describe highlights the importance of considering a diagnosis of PML early (<1 year) after lung transplant.
Insights
Progressive multifocal leukoencephalopathy (PML) is a rare, fatal CNS disease. Early diagnosis of PML within a year after lung transplant is crucial.
Area of Science:
- Neurology
- Infectious Diseases
- Transplant Medicine
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare and fatal demyelinating disease affecting the central nervous system (CNS).
- PML is caused by the JC virus, often reactivating in immunocompromised individuals.
- Lung transplant recipients are a vulnerable population for opportunistic infections like PML.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
10:01Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012